Human Adipose-Derived Stem Cells (ADSCs) are extracted from human lipoaspirate tissue obtained during elective liposuction surgeries. These cells are available from both healthy donors and patients. ADSCs exhibit phenotypic and functional characteristics similar to bone marrow-derived mesenchymal stem cells.

• Purity >90% by flow cytometry
• Test negative for Hepatitis B and C, HIV 1/2, HTLV-I/II, HIV-1/HCV/HBV
• Cryopreserved in CryoStor® CS10 media

Extensive research has been conducted on ADSCs, referred to by various terms such as preadipocytes, adipose-derived mesenchymal stem cells (AD-MSCs), adipose MSCs (AMSCs), adipose-derived adult stem (ADAS) cells, and adipose stromal/stem cells (ASCs). Normal human ADSCs have demonstrated the ability to differentiate into multiple lineages, including chondrogenic, osteogenic, adipogenic, and neural.
ADSCs have been widely utilised in studies focused on stem cell differentiation, regenerative medicine, and cell therapy.

Cells were collected from from a healthy human donors using permission forms and procedures that have been approved by the Institutional Review Board (IRB).

Storage: For prolonged cell preservation or resuscitation, it is recommended to prepare the cells for extended storage in the vapor phase of liquid nitrogen. Storage of cells in the liquid phase of nitrogen is strongly discouraged to prevent potential cross-contamination risks when removing from storage. Long-term storage under −175 °C and for short-term storage, about one or two weeks at −80 °C is permitted, but it is recommended to minimise this duration to ensure optimal stability. Thawed samples should be used immediately and not stored.